Skip to content

Effect of Osteopathic Manipulative Treatment on Pain in Preterms

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02146677
Enrollment
120
Registered
2014-05-26
Start date
2014-06-30
Completion date
2015-09-30
Last updated
2015-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prematurity

Keywords

prematurity, newborns, pain, cost

Brief summary

Osteopathic manipulative treatment (OMT) has been used to treat term and preterm newborns. Recent studies demonstrated the effectiveness of OMT in reducing length of stay and costs (Cerritelli, 2013) as well as the likelihood of gastrointestinal episodes (Pizzolorusso 2011). Moreover it was reported the absence of adverse events and side effects considering the approach safe (Cerritelli 2013, 2014). OMT was extensively used to treat, prevent and manage pain symptoms. Numerous research was published addressing acute and chronic pain in different medical conditions. However, no trials were carried out on pain in newborns. The aim of the present clinical trial is to explore the effectiveness of OMT in reducing pain in a sample of preterm infants.

Interventions

OTHEROsteopathic manipulative treatment
OTHERSham therapy
OTHERUsual care

Sponsors

European Institute for Evidence Based Osteopathic Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
26 Weeks to 37 Weeks
Healthy volunteers
No

Inclusion criteria

* preterm infants * written informed consent by parents or legal guardians * preterms born in the same hospital

Exclusion criteria

* Gestational age \> 37 weeks * genetic disorders * congenital disorders * cardiovascular abnormalities * proven or suspected necrotized enterocolitis with or without gastrointestinal perforation * proven or suspected abdominal obstruction * pre/post surgery patients * pneumoperitoneum * atelectasis * Newborn from an HIV seropositive/drug addicted mother * respiratory disorders * transferred to/from other hospital * admitted for preterminal comfort care (defined as neither intubation nor cardio-respiratory resuscitation)

Design outcomes

Primary

MeasureTime frame
changes from baseline in pain using Premature Infant Pain Profile (PIPP)baseline and end of hospitalization, average length of hospitalization expected 4 weeks

Secondary

MeasureTime frame
Number of days of length of stayparticipants will be followed for the duration of hospital stay, an expected average of 4 weeks

Other

MeasureTime frame
Neonatal intensive care unit costparticipants will be followed for the duration of hospital stay, an expected average of 4 weeks

Countries

Italy

Contacts

Primary ContactFrancesco Cerritelli, DO
francesco.cerritelli@ebom.it+393394332801

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 18, 2026